GeoVax Labs receives Nasdaq notice of stockholders' equity compliance failure
GeoVax Labs received notice on July 7, 2026, from Nasdaq that it failed to meet the $2,500,000 minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) and did not meet alternative compliance metrics. The company has 45 calendar days, until August 21, 2026, to submit a plan to regain compliance; if accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of notice. The stock continues to trade under symbol GOVX; if the company fails to regain compliance, Nasdaq would issue a delisting determination, though the company could request a hearing before a Nasdaq Hearings Panel to contest delisting.
Key facts
- Notice received July 7, 2026
- $2,500,000 minimum stockholders' equity requirement not met
- 45 calendar days to submit compliance plan; deadline August 21, 2026
- Nasdaq Listing Rule 5550(b)(1)
- Possible extension of up to 180 calendar days if plan is accepted
- Stock continues trading under symbol GOVX
- Company entitled to hearing before Nasdaq Hearings Panel if delisting determination issued
Why it matters
GeoVax Labs faces a near-term listing compliance crisis; failure to submit an acceptable remediation plan or achieve compliance within any granted extension period would trigger a delisting determination from Nasdaq, though the company may appeal through a Hearings Panel process.
Share
Derived from 8-K filed 2026-07-10. Not investment advice. View the source filing on SEC.gov →